AzTrials
AzTrials

Patient DischargePhase 2/3NCT00364117

Remote Presence Timely Discharge Management

A Phase 2/3 study testing Timely Discharge (Remote Presence Technology) in people with Patient Discharge, run by Hackensack Meridian Health at 1 site in United States.

Withdrawn

Withdrawn. The study stopped before anyone enrolled.

Official record
Search all trials

Trial summary

The purpose of this study is to integrate Remote Presence technology in order to increase the number of timely patient discharges before 11 am from the medical center. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Patient Discharge
What is being tested?
Timely Discharge (Remote Presence Technology)
How many people
0 participants
Where
1 siteUnited States
Study dates
Aug 2006to Aug 2008
Phase
Phase 2/3
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Adult patients
  • Primary care physicians in internal medicine
  • Primary care physicians/practice group with established discharge pattern after 11 am
  • Primary care physicians/practice group with fast access digital subscriber line (DSL) 300 kilobytes per second
  • Primary care physicians/practice group who have Hackensack Medical Center (HUMC) intranet access from pre-determined location

Who cannot join

  • Non-English speaking patients
  • Patients requiring acute level of care on the day of discharge

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Hackensack University Medical Center

    Hackensack, New Jersey, 07601

Other trials in United States

About this study

The purpose of this study is to integrate Remote Presence technology in order to increase the number of timely patient discharges before 11 am from the medical center.

Read the detailed description

Reduction in beds coupled with the increased need for health care services has led to a supply and demand struggle or capacity management challenge for health care facilities. This is now recognized as a major public health issue. The impact is readily seen as overcrowding in emergency departments. At present 76% of hospitals' emergency departments (ETDs) are at or over capacity with 33% reporting ambulance diversions, the most common sign of overcapacity within a health care facility. Compounding the physical capacity problem is the "human capacity strain" as admitted patients remain in the ETD for prolonged periods waiting for beds. Delayed admission to patient care units significantly strains the financial resources, impedes "patient flow" ultimately impacting the quality of care, patient satisfaction and the "bottom line." Discharge before 11 am optimizes the availability of hospital beds to meet admission demands thereby avoiding a surge over capacity or "patient back log", ambulance diversions in ETD; the post anesthesia recovery unit, admissions office and critical care units. Conversely competing needs for the attending physician's physical presence off of the hospital premises; off of the unit (private practice and meetings) often delays patient discharge from before 11 am to the afternoon and evening.

Being tested
Timely Discharge (Remote Presence Technology)
Keywords
150 discharges, adults, Internal Medicine

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Timely Discharge (Remote Presence Technology)Behavioural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Timely patient discharge before 11 am

  2. Patient satisfaction

  3. Employee satisfaction

Secondary outcomes (3)
  1. Employee satisfaction

  2. Physician satisfaction

  3. Financial impact on medical center

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted15 Aug 2006 (estimated)
  2. Study startAug 2006
  3. Primary completionAug 2008 (estimated)
  4. Study completionAug 2008

Why it stopped: No patients were enrolled

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2/3
Primary purpose
Treatment
Allocation
Non-randomised
Intervention model
Single group
Masking
None (open label)
Enrolment
0 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00364117
Sponsor's protocol ID
06.01.052
Other IDs
Intouch Technologies Inc, Horizon Blue Cross Blue Shield
Status last verified
May 2013
First submitted
11 Aug 2006
Last updated
7 May 2013
Results posted
No

Questions about this trial

What is this clinical trial studying?

A Phase 2/3 study testing Timely Discharge (Remote Presence Technology) in people with Patient Discharge, run by Hackensack Meridian Health at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: withdrawn, as of the sponsor's last update on 7 May 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this combined phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was withdrawn before enrolling participants, so there are no results.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Timely patient discharge before 11 am. The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 May 2013; AzTrials last refreshed its copy on 28 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in